BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17947383)

  • 1. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
    Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.
    Sato Y; Ramalanjaona N; Huet T; Potier N; Osz J; Antony P; Peluso-Iltis C; Poussin-Courmontagne P; Ennifar E; Mély Y; Dejaegere A; Moras D; Rochel N
    PLoS One; 2010 Nov; 5(11):e15119. PubMed ID: 21152046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
    J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
    Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
    J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand Design for Modulation of RXR Functions.
    Martínez C; Souto JA; de Lera AR
    Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
    le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
    Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.
    Su Y; Zeng Z; Chen Z; Xu D; Zhang W; Zhang XK
    Curr Top Med Chem; 2017; 17(6):663-675. PubMed ID: 27320331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids.
    le Maire A; Rey M; Vivat V; Guée L; Blanc P; Malosse C; Chamot-Rooke J; Germain P; Bourguet W
    J Mol Endocrinol; 2022 Oct; 69(3):377-390. PubMed ID: 35900852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional insights into the ligand-binding domain of a nonduplicated retinoid X nuclear receptor from the invertebrate chordate amphioxus.
    Tocchini-Valentini GD; Rochel N; Escriva H; Germain P; Peluso-Iltis C; Paris M; Sanglier-Cianferani S; Van Dorsselaer A; Moras D; Laudet V
    J Biol Chem; 2009 Jan; 284(3):1938-48. PubMed ID: 18986992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
    Wagner CE; Jurutka PW
    Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
    Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
    J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations.
    le Maire A; Teyssier C; Balaguer P; Bourguet W; Germain P
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12.
    Love JD; Gooch JT; Benko S; Li C; Nagy L; Chatterjee VK; Evans RM; Schwabe JW
    J Biol Chem; 2002 Mar; 277(13):11385-91. PubMed ID: 11782480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoid X receptor: a nuclear receptor that modulates the sleep-wake cycle in rats.
    Murillo-Rodríguez E; Millán-Aldaco D; Arankowsky-Sandoval G; Yamamoto T; Cid L; Monteiro D; Rocha NB; Telles-Correia D; Teixeira DS; Veras AB; Budde H; Machado S; Imperatori C; Torterolo P
    Psychopharmacology (Berl); 2020 Jul; 237(7):2055-2073. PubMed ID: 32472163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.
    Ohsawa F; Yamada S; Yakushiji N; Shinozaki R; Nakayama M; Kawata K; Hagaya M; Kobayashi T; Kohara K; Furusawa Y; Fujiwara C; Ohta Y; Makishima M; Naitou H; Tai A; Yoshikawa Y; Yasui H; Kakuta H
    J Med Chem; 2013 Mar; 56(5):1865-77. PubMed ID: 23391145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254).
    Jurutka PW; Kaneko I; Yang J; Bhogal JS; Swierski JC; Tabacaru CR; Montano LA; Huynh CC; Jama RA; Mahelona RD; Sarnowski JT; Marcus LM; Quezada A; Lemming B; Tedesco MA; Fischer AJ; Mohamed SA; Ziller JW; Ma N; Gray GM; van der Vaart A; Marshall PA; Wagner CE
    J Med Chem; 2013 Nov; 56(21):8432-54. PubMed ID: 24180745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative retinoid X receptor (RXR) ligands.
    Krężel W; Rühl R; de Lera AR
    Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.